Boehringer Ingelheim and King』s College London Join Forces to Progress New Therapeutic Concepts in Major Depressive Disorder and Schizophrenia

INGELHEIM, Germany & LONDON–(BUSINESS WIRE)–Boehringer Ingelheim and the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King』s College London today announced a new coll…